Pegylated liposomal tumor necrosis factor-a results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with Doxil® in soft tissue sarcoma-bearing rats

Timo ten Hagen, ALB Seynaeve, Sandra van Tiel, DJ Ruiter, Lex Eggermont

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)115-120
Number of pages6
JournalInternational Journal of Cancer
Issue number1
Publication statusPublished - 2002

Research programs

  • EMC MM-03-47-11

Cite this